GLP-1(7-36) acetate is widely used in the treatment of type 2 diabetes due to its ability to enhance insulin secretion in a glucose-dependent manner. It helps regulate blood sugar levels by slowing gastric emptying and reducing appetite, which also supports weight management in patients. Additionally, it is employed in research to study its effects on pancreatic beta cells and its potential role in improving cardiovascular health. Its therapeutic applications extend to managing metabolic disorders, making it a valuable component in diabetes care and related studies.